- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 8.95M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex restated | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$118.23K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $72.61K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $108.71K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $110.9K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $103.53K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $197.95K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$24.58M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$23.71M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$17.83M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $25.14M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $24.77M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $25.29M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $24.94M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $310.16K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $798.87K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $715.27K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.23M |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.23M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $463.93K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.17M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.5M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.2M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$461.9K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $30.67K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $2.03K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $57.25K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $252 |
| Revenue | Q1 2026 · Mar 31, 2026 | $87.92K |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $2.28K |